# Cardinal Health Inc. (CAH)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $53.91B  
**Price:** $222.77 (+2.99%)

> Cardinal Health Inc. is a healthcare services and products company that supports the movement of medicines, medical supplies, and clinical products across the healthcare system. The company distributes branded, generic, and specialty pharmaceuticals to pharmacies, hospitals, and other healthcare providers, while also supplying medical-surgical products and equipment to facilities in North America, Europe, and Asia. Its offerings include customized solutions for hospitals, health systems, ambulatory surgery centers, clinical laboratories, and physician offices, along with performance and data solutions designed to improve supply chain efficiency. Cardinal Health plays a central role in medical distribution, helping connect manufacturers, providers, and care settings through large-scale logistics and product support. Headquartered in Dublin, Ohio, Cardinal Health is a major participant in the healthcare supply chain and serves a broad range of customers across the industry.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $222.58B | $8.17B | $2.27B | $1.56B | — |
| 2024 | $226.83B | $7.41B | $1.24B | $852M | — |
| 2023 | $204.98B | $6.87B | $752M | $330M | — |
| 2022 | $181.33B | $6.48B | -$607M | -$938M | — |
| 2021 | $162.47B | $6.78B | $472M | $611M | — |
| 2020 | $152.92B | $6.87B | -$4.10B | -$3.70B | — |
| 2019 | $145.53B | $6.83B | $2.06B | $1.36B | — |
| 2018 | $136.81B | $7.18B | $126M | $256M | — |
| 2017 | $129.98B | $6.54B | $2.12B | $1.29B | — |
| 2016 | $121.55B | $6.54B | $2.46B | $1.43B | — |
| 2015 | $102.53B | $5.71B | $2.16B | $1.22B | — |
| 2014 | $91.08B | $5.16B | $1.89B | $1.17B | — |
| 2013 | $101.09B | $4.92B | $996M | $334M | — |
| 2012 | $107.55B | $4.54B | $1.79B | $1.07B | — |
| 2011 | $102.64B | $4.16B | $1.51B | $959M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $53.12B | $55.90B | -$2.78B | $3.87B | — |
| 2024 | $45.12B | $48.33B | -$3.21B | $5.13B | — |
| 2023 | $43.35B | $46.31B | -$2.96B | $4.08B | — |
| 2022 | $43.88B | $44.59B | -$709M | $4.72B | — |
| 2021 | $44.45B | $42.66B | $1.79B | $3.41B | — |
| 2020 | $40.77B | $38.98B | $1.79B | $2.77B | — |
| 2019 | $40.96B | $34.63B | $6.33B | $2.53B | — |
| 2018 | $39.95B | $33.89B | $6.06B | $1.76B | — |
| 2017 | $40.11B | $33.30B | $6.81B | $6.88B | — |
| 2016 | $34.12B | $27.57B | $6.55B | $2.36B | — |
| 2015 | $30.14B | $23.89B | $6.26B | $4.62B | — |
| 2014 | $26.03B | $19.63B | $6.40B | $2.87B | — |
| 2013 | $25.82B | $19.84B | $5.97B | $1.90B | — |
| 2012 | $24.26B | $18.02B | $6.24B | $2.27B | — |
| 2011 | $22.85B | $17.00B | $5.85B | $1.93B | $2.50B |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $2.40B | $547M | $1.85B |
| 2024 | $3.76B | $511M | $3.25B |
| 2023 | $2.84B | $481M | $2.36B |
| 2022 | $3.17B | $387M | $2.79B |
| 2021 | $2.43B | $400M | $2.03B |
| 2020 | $1.96B | $375M | $1.58B |
| 2019 | $2.72B | $328M | $2.39B |
| 2018 | $2.77B | $384M | $2.38B |
| 2017 | $1.18B | $387M | $797M |
| 2016 | $2.97B | $465M | $2.51B |
| 2015 | $2.54B | $300M | $2.24B |
| 2014 | $2.52B | $249M | $2.27B |
| 2013 | $1.73B | $195M | $1.53B |
| 2012 | $1.18B | $260M | $916M |
| 2011 | $1.40B | $291M | $1.10B |

Source: [CompaniesByCap](https://companiesbycap.com/company/CAH)